QuidelOrtho Corp
For the period ended Dec 28, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
At December 28, 2025, our material operating locations, which we define as the facilities we lease with more than 75,000 square feet plus all owned facilities with more than 20,000 square feet, were as follows:
| Location | Status | Lease Term | SquareFootage | Primary Use |
|---|---|---|---|---|
| Raritan, NJ | Owned | N/A | 569,000 | Administrative offices, R&D and manufacturing |
| Rochester, NY (513 Technology Blvd) | Owned | N/A | 438,628 | Manufacturing |
| San Diego, CA (Summers Ridge) | Leased | 2033 - options to extend for two additional 5-year periods | 316,531 | Administrative offices, sales and marketing, R&D and manufacturing (principal executive offices) |
| Rochester, NY (100 Indigo Creek) | Owned | N/A | 260,221 | Office, R&D |
| Pencoed, Wales (1) | Owned | N/A | 198,380 | Office, manufacturing |
| Athens, OH | Leased | 2027 | 149,240 | Administrative offices, sales and marketing, R&D and manufacturing |
| Carlsbad, CA (Rutherford) | Leased | 2036 - options to extend for two additional 5-year periods | 128,745 | Manufacturing |
| Memphis, TN | Leased | 2026 | 116,500 | Warehouse |
| San Diego, CA (Waples Ct.) | Leased | 2031 - options to extend for two additional 5-year periods | 106,412 | Office, light manufacturing, storage, packaging, assembly and distribution |
| Rochester, NY (130 Indigo Creek) | Owned | N/A | 103,138 | Office, R&D |
| Strasbourg, France | Owned | N/A | 97,951 | Warehouse, service |
| Rochester, NY (1000 Lee Road) | Leased | 2027 | 89,114 | Manufacturing |
| Pompano Beach, FL | Owned | N/A | 21,500 | Manufacturing |
(1) In December 2024, the Company entered into an agreement for the expansion of the office building and manufacturing facility, which is expected to be complete and fully operational in early 2027.
We believe that our facilities are adequate for our current needs, and we currently do not anticipate any material difficulty in renewing any of our leases as they expire or securing additional or replacement facilities, in each case, on commercially reasonable terms. However, in anticipation of our growth strategy, we may pursue additional facilities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.